comparemela.com

Latest Breaking News On - Posaconazole delayed release tablets - Page 1 : comparemela.com

Stocks to Watch: HUL, IndiGo, Sun Pharma, RIL, Adani Group, GAIL

Parsvnath Developers will be among the stocks in focus as it will declare its December quarter earnings today.

India generalUnited statesSun pharmaAutosystemtechnik gmbVinay malhotraIndia ltdSintex industriesAssets care reconstruction enterprise ltdAgatsa software privateReactivate brands internationalHindustan unilever ltdUma global foods pte ltdTurkish airlinesSamvardhana motherson internationalSamvardhana motherson international ltdPi industries

Biocon Recalls 3,665 Bottles Of Antifungal Drug In US For Failed Specifications

Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in the US market for "failed degradation specifications", according to the US Food and Drug Administration (USFDA).

Biocon pharmaDrug administrationBiocon pharma incEnforcement reportPosaconazole delayed release tabletsNew jersey based biocon pharma incDegradation specificationsHigh out of specificationIselin based biocon pharma incComplete response letterBiocon biologicAntifungal drugDrug recall

Biocon recalls 3,665 bottles of antifungal drug in US for failed degradation specifications

USFDA noted that the New Jersey-based Biocon Pharma Inc is recalling the affected lot due to ‘Failed Impurities/Degradation Specifications: High Out Of Specification degradation results’.

Biocon pharmaBiocon pharma incEnforcement reportPosaconazole delayed release tabletsNew jersey based biocon pharma incDegradation specificationsHigh out of specificationIselin based biocon pharma incComplete response letterBiocon biologicAntifungal drug

Dr Reddy s launches Posaconazole Tablets in US market

Dr. Reddy’s Posaconazole Delayed-Release Tablets are available in 100 mg strength in bottle count sizes of 60.

Drug administrationReddy laboratories ltdPosaconazole delayed release tabletsDelayed release tablets

Dr Reddy s Laboratories Announces the Launch of Posaconazole Delayed-Release Tablets in the U S Market

20.04.2022 - Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Posaconazole Delayed-Release Tablets, 100 mg, the therapeutic .

United statesExchange commissionReddy laboratories ltdPosaconazole delayed release tabletsPosaconazole tabletsAnnual reportDr reddys laboratories

vimarsana © 2020. All Rights Reserved.